Health Insurance - Coverage for Specialty Drugs - Rheumatologic Conditions

Summary

The bill bars insurers, nonprofit health plans and HMOs from denying coverage for certain specialty drugs used to treat rheumatologic conditions when the drugs are administered or dispensed by an in‑network rheumatology provider that follows state regulations. It also requires reimbursement rates to be negotiated with those providers and limits the rates to non‑hospital levels, preventing higher payments to designated specialty pharmacies. The measure seeks to improve patient access and create fairer payment rules for office‑based drug dispensing.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Hearings

• Health — Bill Hearing
  Health · Mar 13, 2026

History

1. Mar 13, 2026Hearing canceled
2. Mar 13, 2026Hearing 3/13 at 3:00 p.m.
3. Mar 13, 2026Hearing 3/13 at 1:30 p.m.
4. Feb 13, 2026Hearing 3/13 at 1:00 p.m.
5. Feb 13, 2026First Reading Health

Sponsors

• Taveras · sponsor
• Lehman
• Williams

Bill text

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Topics

Share